267 related articles for article (PubMed ID: 32471882)
1.
Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L
J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882
[TBL] [Abstract][Full Text] [Related]
2. Distinct gene expression characteristics in epithelial cell-
Zhang D; Hou J; Wu Y; Liu Y; Li R; Xu T; Liu J; Pan Y
Int J Med Sci; 2019; 16(10):1320-1327. PubMed ID: 31692996
[No Abstract] [Full Text] [Related]
3. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment.
Guo ZC; Jing SL; Jia XY; Elayah SA; Xie LY; Cui H; Tu JB; Na SJ
Inflamm Res; 2024 May; 73(5):693-705. PubMed ID: 38150024
[TBL] [Abstract][Full Text] [Related]
4. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention.
Qin Y; Li Z; Liu T; Ma J; Liu H; Zhou Y; Wang S; Zhang L; Peng Q; Ye P; Duan N; Wang W; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):206. PubMed ID: 38644421
[TBL] [Abstract][Full Text] [Related]
5. Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China.
Li C; Li M; Wei W; Wang Z; Yu J; Gong Z
BMC Cancer; 2024 Apr; 24(1):534. PubMed ID: 38671413
[TBL] [Abstract][Full Text] [Related]
6. Induction of B7-H1 receptor by bacterial cells fractions of Porphyromonas gingivalis on human oral epithelial cells: B7-H1 induction by Porphyromonas gingivalis fractions.
Groeger S; Jarzina F; Mamat U; Meyle J
Immunobiology; 2017 Feb; 222(2):137-147. PubMed ID: 28164807
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
Lan Z; Zou KL; Cui H; Zhao YY; Yu GT
Mol Oncol; 2024 May; 18(5):1174-1188. PubMed ID: 37666495
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis-stimulated macrophage subsets exhibit differential induction and responsiveness to interleukin-10.
Foey AD; Habil N; Al-Shaghdali K; Crean S
Arch Oral Biol; 2017 Jan; 73():282-288. PubMed ID: 27816791
[TBL] [Abstract][Full Text] [Related]
9. IRF6 Regulates the Expression of IL-36γ by Human Oral Epithelial Cells in Response to Porphyromonas gingivalis.
Huynh J; Scholz GM; Aw J; Kwa MQ; Achuthan A; Hamilton JA; Reynolds EC
J Immunol; 2016 Mar; 196(5):2230-8. PubMed ID: 26819203
[TBL] [Abstract][Full Text] [Related]
10. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis.
Groeger S; Domann E; Gonzales JR; Chakraborty T; Meyle J
Immunobiology; 2011 Dec; 216(12):1302-10. PubMed ID: 21723642
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of Interleukin-6 and Titers of Antibodies Against
Park DG; Woo BH; Lee BJ; Yoon S; Cho Y; Kim YD; Park HR; Song JM
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167516
[TBL] [Abstract][Full Text] [Related]
13. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
14. Immune response of macrophages induced by Porphyromonas gingivalis requires HmuY protein.
Gmiterek A; Kłopot A; Wójtowicz H; Trindade SC; Olczak M; Olczak T
Immunobiology; 2016 Dec; 221(12):1382-1394. PubMed ID: 27473343
[TBL] [Abstract][Full Text] [Related]
15. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential.
Woo BH; Kim DJ; Choi JI; Kim SJ; Park BS; Song JM; Lee JH; Park HR
Oncotarget; 2017 Jul; 8(29):46981-46992. PubMed ID: 28388583
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid-Containing Outer Membrane Vesicles Serve as a Delivery Vehicle To Limit Macrophage Immune Response to Porphyromonas gingivalis.
Rocha FG; Ottenberg G; Eure ZG; Davey ME; Gibson FC
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33361202
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection.
Huck O; Al-Hashemi J; Poidevin L; Poch O; Davideau JL; Tenenbaum H; Amar S
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069815
[TBL] [Abstract][Full Text] [Related]
18. Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in mice.
Lam RS; O'Brien-Simpson NM; Lenzo JC; Holden JA; Brammar GC; Walsh KA; McNaughtan JE; Rowler DK; Van Rooijen N; Reynolds EC
J Immunol; 2014 Sep; 193(5):2349-62. PubMed ID: 25070844
[TBL] [Abstract][Full Text] [Related]
19. [Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization].
Zheng SZ; Meng L; Ren FL; Ren CX; Li X; Wang DD; Sun HC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):510-516. PubMed ID: 37248576
[TBL] [Abstract][Full Text] [Related]
20. Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma.
Ye XJ; Yang JG; Tan YQ; Chen XJ; Zhou G
Anticancer Agents Med Chem; 2021; 21(6):766-774. PubMed ID: 32748759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
